Entering text into the input field will update the search result below

More on Akebia Q2 results

Aug. 11, 2014 8:30 AM ETAkebia Therapeutics, Inc. (AKBA) StockBy: Douglas W. House, SA News Editor
  • Akebia Therapeutics (NASDAQ:AKBA) Q2 results: Revenues: $0; Net Loss: ($7.6M) (-169.2%); Loss Per Share: ($0.39) (+99.6%); Quick Assets: $124.2M (+282.2%).
  • No financial guidance given.

Recommended For You

More Trending News

About AKBA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AKBA--
Akebia Therapeutics, Inc.